The American College of Cardiology publishes new recommendations for peripheral artery disease diagnosis and treatment among adults with diabetes.

Because it causes tissue damage and tissue death in the legs, feet, and toes, PAD is implicated in 150,000 lower-limb ...

Bempedoic Acid Highlighted by ACC for LDL-C Lowering in Patients with Peripheral Artery Disease and Diabetes Based on Proven Cardiovascular and ...

In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD) ...

Global Atherectomy Devices Market OverviewThe global atherectomy devices market is expected to witness substantial growth, with a projected CAGR of around 8% during the forecast period. Several key ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Patients on tirzepatide also experienced more metabolic benefits, such as greater reductions in weight and HbA1c, compared ...

Symvess is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, ...

An AHA scientific statement provides a framework for coronary revascularization in older adults, focusing on individualized care and patient preferences.

Dr Dale Hansen of Memphis Vascular Center explains PAD symptoms, modern balloon-based treatments and why early evaluation is ...

A vascular surgeon successfully treated a young patient at risk of leg amputation due to PAD with a structured intermittent walking program. This exercise regimen, involving brisk walking intervals ...

The PAD Collaborative, a group of 17 organizations convened by the American Heart Association to address the growing burden of peripheral artery disease (PAD) in the United States, has released a new ...